Gabelli Funds LLC Reduces Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Gabelli Funds LLC decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 3.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 216,337 shares of the health services provider’s stock after selling 7,065 shares during the quarter. Gabelli Funds LLC owned about 0.66% of Amedisys worth $19,860,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Allianz Asset Management GmbH raised its holdings in shares of Amedisys by 146.0% during the 4th quarter. Allianz Asset Management GmbH now owns 39,855 shares of the health services provider’s stock worth $3,789,000 after acquiring an additional 23,655 shares during the period. Water Island Capital LLC raised its stake in Amedisys by 185.0% during the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after purchasing an additional 461,368 shares during the period. Nomura Holdings Inc. boosted its holdings in Amedisys by 604.2% in the 4th quarter. Nomura Holdings Inc. now owns 49,297 shares of the health services provider’s stock valued at $4,686,000 after purchasing an additional 42,297 shares during the last quarter. Norges Bank acquired a new position in Amedisys in the 4th quarter valued at about $34,032,000. Finally, SG Americas Securities LLC grew its stake in shares of Amedisys by 41.6% in the 2nd quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider’s stock valued at $3,517,000 after buying an additional 11,264 shares during the period. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Stock Up 0.1 %

Shares of NASDAQ AMED opened at $97.30 on Monday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The business’s 50 day moving average is $97.69 and its two-hundred day moving average is $94.84. Amedisys, Inc. has a 52-week low of $89.55 and a 52-week high of $98.95. The firm has a market cap of $3.18 billion, a price-to-earnings ratio of -152.03, a PEG ratio of 1.89 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, July 24th. The health services provider reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.10. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. The firm had revenue of $591.19 million for the quarter, compared to the consensus estimate of $579.34 million. Research analysts predict that Amedisys, Inc. will post 4.66 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently commented on AMED. William Blair cut Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a research note on Monday, July 29th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a research report on Thursday, July 25th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.